chrisvoncsefalvay/vaers-outcomes huggingface dataset:
he till had COVID-19; he till had COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-HCP) from medical information team for a Pfizer sponsored program (159558).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "he still had COVID-19". The patient underwent the following laboratory tests and procedures: sars-cov-2 test positive, notes had both the vaccine and a booster shot but he still had COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pyrexia, headache, nausea, full body chills, fatigue, and full body muscle soreness.
at 1:00 pm the next day, experienced fever, body aches, chills, headache. took tylenol 650mg every 4 hours, left bicept on left arm started getting red, warm, itchy, at about 5pm on 10/17/21. all symptoms emcept arm have resolved as of 10/19/21 excpet arm. arm is still tender/red/itchy/swollen.   presented to pharmacy on 10/19/21 @ 06:00 pm when this VAERS was completed.
Patient reports prolonged pain/discomfort in shoulder which began immediately after  the shot was administered. They report a decrease in range of motion. Both symptoms persist now, even 3 weeks after the vaccination was received.
Information regarding PREVNAR 13 was received from a healthcare professional regarding a 2-month-old female patient who experienced left thigh swelling.  The patient received a dose on 05-APR-2010.  Relevant medical history was not provided.  Indication for PREVNAR 13 was immunisation.  Product was administered on 05-Apr-2010.  Dose regimen was 1 dose 1 time per day (intramuscular).  Additional suspect medication included HEPATITIS B Vaccine.  Concomitant medications included "Penicil" vaccine.  The patient experienced left thigh swelling (injection site swelling) in Apr-2010.  Treatment included a cold and warm compress.  Patient recovered in April 2010.  No additional information was available at the time of this report.
The symptoms started the same day and I felt tired sore muscles nausea vomiting diarrhea and chills
After giving the FLUARIX patient said he is blacking out, he was conscious and able to hear what we are saying. After two to three minutes he started feeling better. He wanted to sit on the floor and he sit on the floor with some help. After 5 minutes patient said he is feeling better and he got up by his own and walked out by his own before the paramedics come to pharmacy. Patient had a history of reacting this way with other vaccines administered at his Dr office.
3 Pfizer and 3 Moderna; No adverse event; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3 Pfizer and 3 Moderna) and NO ADVERSE EVENT (No adverse event) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form, first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and third dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form., second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form and first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3 Pfizer and 3 Moderna) and NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3 Pfizer and 3 Moderna) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant medication was reported.  Reportedly, patient got 3 Pfizer COVID-19 vaccines and 3 Moderna. He mentioned that he felt good.  No treatment information was provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
She has had COVID-19 twice; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (She has had COVID-19 twice) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (She has had COVID-19 twice). At the time of the report, COVID-19 (She has had COVID-19 twice) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment medication reported.   Reporter did not allow further contact
This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (some fatigue), PAIN (some body ache), VACCINATION SITE ERYTHEMA (injection site became red), SWELLING (swollen) and DISCOMFORT (uncomfortable to touch) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (some fatigue), PAIN (some body ache), VACCINATION SITE ERYTHEMA (injection site became red), SWELLING (swollen), DISCOMFORT (uncomfortable to touch), RASH MACULAR (huge red spot), PAIN (painful), PRURITUS (itching), AXILLARY PAIN (under armpit it was painful), TENDERNESS (under armpit tenderness), ERYTHEMA (redness has now spreaded down to her elbow), SKIN EXFOLIATION (skin is pealing off) and LIMB DISCOMFORT (arm it feels like it pulling somethin). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FATIGUE (some fatigue), PAIN (some body ache), VACCINATION SITE ERYTHEMA (injection site became red), SWELLING (swollen), DISCOMFORT (uncomfortable to touch), RASH MACULAR (huge red spot), PAIN (painful), PRURITUS (itching), AXILLARY PAIN (under armpit it was painful), TENDERNESS (under armpit tenderness), ERYTHEMA (redness has now spreaded down to her elbow), SKIN EXFOLIATION (skin is pealing off) and LIMB DISCOMFORT (arm it feels like it pulling somethin) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication provided.
Arm muscle sore and hurting after flu shot.  It continues to be sore and hurting 2 months after Flu shot immunization.
(R) arm pain -> site of TRUMENBA. Fever/cough/runny nose.
pain, edema/cellulitis of lt arm from deltoid to above elbow, erythema;rx cold packs, advil, duricef x 10 days;
pt  states shot was given in lower left arm on 12/4/2020.. it has hurt since she was given the shot.. on sunday 12/13/20 her arm started to swell .. she states the md stated her bone was infection from the shot given too low on the arm.. she was referred to an orthopedic
Patient developed severe body aches, chills, swelling of tongue and facial redness. The next day she had severe weakness and could not walk.
Psoriasis; joint pain; This is a spontaneous report from a contactable consumer (patient) reported himself. A 68-years-old male patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: unknown), via an unknown route of administration on an unknown date (at the age of 68-years-old) as dose number unknown, single for COVID-19 immunization. The patient's medical history was not reported. The patient also received tofacitinib citrate (XELJANZ, strength: 5 mg) for an unknown indication, start and stop dates were not reported. The patient's medical history and concomitant medication were not reported. Patient due for a refill, he stated, "I have been without medication almost two months. My Psoriasis and joint pain have become severe, and I have also received the Covid-19 vaccine." Patient was prescribed Xeljanz 5mg. The action taken in response to the event for tofacitinib citrate was unknown. The outcome of the events was unknown.  No follow-up attempts are possible; Information about Lot/Batch number cannot be obtained.
usual sore arm; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (usual sore arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced PAIN IN EXTREMITY (usual sore arm). On 30-Jan-2021, PAIN IN EXTREMITY (usual sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment drug details was reported.   This case was linked to MOD-2021-303300, MOD-2021-303279 (Patient Link).
The pt complained of malaise, dizziness, diaphoresis, dyspepsia, cephalgia, extreme fatigue, general myalgia.
Patient feeling weak  And was acting confused per husband today.  She has a chronic cough- no change.  Received second dose of Moderna Covid vaccine yesterday.  Denies headache, chest pain, shortness of breath, nausea, vomiting, diarrhea, fever, chills or dysuria.  Has not taken anything for her temperature today.  Denies recent illness.
My head gets headaches off and on; My R arm is very sore to the touch and when moving my arm it is very sore; This is a spontaneous report from a contactable consumer. A 68-years-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE,Solution for injection,Batch/Lot Number: EL9261), via an unspecified route of administration, administered in Arm Right on 27Jan2021 13:30 (the day of vaccination) (at the age of 68 years) as SINGLE DOSE for covid-19 immunisation. Medical history included gluten sensitivity, food allergy, dairy intolerance, hypothyroidism, dyspnoea, balance disorder, osteoarthritis, sjogren-larsson syndrome. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not tested for COVID-19 post vaccination and not had COVID prior to vaccination. Concomitant medication(s) included levothyroxine sodium (LEVOTHYROXIN), cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]), vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), colecalciferol (VITAMIN D [COLECALCIFEROL]). On 27Jan2021 16:00, the patient experienced my head gets headaches off and on, my r arm is very sore to the touch and when moving my arm it is very sore. The  outcome of events were not recovered.
Initial information received on 13-Dec-2018 regarding an unsolicited valid non-serious case received from a physician. This case involves a 76-years-old male patient who received first dose of suspect  MENACTRA (lot number, expiry date, dose, dose in series, route and site of administration were not reported) on 28-Sep-2018. The patient's past medical history included Splenectomy. The patient's past medical treatment(s), vaccination(s), family history and concomitant medications were not provided. It was a case of actual medication error due to inappropriate age at vaccine administration and off label use. It was reported that the physician had two different references that instructs him to administer 2 doses 8 weeks apart and 12 weeks apart. The patient received first dose and did not have any info on the vaccination done at that time. The doctor is very focused on giving the patient a second dose of MENACTRA because of his not having a spleen and being immunosuppressed. It was unknown if any adverse event occurred or not following the vaccination. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: none.
Information has been received from a physician concerning a pt who was vaccinated with varicella virus vaccine live. Two years, post vax, the pt developed a moderate to severe case of chickenpox. Additional information has been requested.
Stroke; Blood clot; This spontaneous case was reported by a consumer and describes the occurrence of CEREBROVASCULAR ACCIDENT (Stroke) and THROMBOSIS (Blood clot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced CEREBROVASCULAR ACCIDENT (Stroke) (seriousness criterion medically significant) and THROMBOSIS (Blood clot) (seriousness criterion medically significant). At the time of the report, CEREBROVASCULAR ACCIDENT (Stroke) and THROMBOSIS (Blood clot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The  concomitant medications on use were not provided.  No laboratory data was provided. No treatment information was provided.  The patient did not have any family history of stroke.  The patient received the vaccine 3 months prior to AEs.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
12/8/07 had temp of 102.4 w/red blotches from neck down right arm. Took hydrocodone-As of 12/10/07 had slight rash down back of arm.
3 months after 2nd injection.  Facial paralysis, right side.  After ruling out stroke at ER diagnosis Bells Palsy
expired dose administered to patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose administered to patients) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose administered to patients). On 06-Jan-2022, EXPIRED PRODUCT ADMINISTERED (expired dose administered to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   Number of doses/vials were 63 doses, 3-4 vials; date the vial was initially stored in the refrigerator was on 01-Dec-2021 and the vial did not undergo any temperature excursions.  It was reported by the reporter that, some patients had reported flu-like symptoms after receiving the vaccination, but she did not have details on that.
Tinnitus in my left ear; This is a spontaneous report from a contactable consumer (reporting for himself). A 40-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 22Apr2021 at 15:00 (Batch/Lot Number: Unknown) as UNKNOWN, SINGLE for COVID-19 immunization. Medical history included high blood pressure and Allergy: Penicillin. The patient's concomitant medications were not reported. On 01May2021 at 15:00, the patient experienced tinnitus in his left ear. The outcome of the event was not recovered. The event results in doctor or other healthcare professional office/clinic visit. The event was considered serious with disability or permanent damage. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19.  Information on the lot/batch number has been requested.
Information has been received from a lawyer regarding a case in litigation concerning female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 02-JUN-2008, the patient was administered the ZOSTAVAX by a physician (lot number, dosage and route of administration not provided). On an unknown date in 2017, the patient was treated by a healthcare provider for the following injury resulting from her ZOSTAVAX use: Shingles. The patient claims damages including: injury to herself and economic losses. The outcome of the shingles is unknown. Additional information has been requested.
1 Day post-little redness, upset stomach, tiredness, headache, light headedness, spot hot to touch. 2 day post-fist sized redness along w/day 1 symptoms.
Case number PHEH2012US006459 is an initial spontaneous report received from a pharmacist on 16 Mar 2012: This report refers to 11-year-old female patient. She was given only the CYW-135 liquid component MENVEO (batch number: unknown) intramuscularly on 16 Mar 2012. No other adverse reaction was reported.
Three days after the vaccination, I woke up with my thyroid visibly swollen and sore.  I had difficulty swallowing.  I have a history of Graves disease but have been in remission for over 10 years with no medication.  I made an initial appointment with a endocrinologist upon the recommendation of my internist.  I could not be seen until June of 2021.  My symptoms persisted until May of 2021.  When I saw the endocrinologist in June I was asymptomatic and the clinical and lab and ultrasound tests were within normal limits.
The pt was given the Hep A vaccine on 10/23/2008 and then given another Hep A on 10-30-08.
After receiving the Td (adult), I went into anaphylactic shock and then passed out.My mother and the nurse got me to revive, although I know the nurse had a syringe of something, I do not know the contents of what was used.While they did not call an ambulance, because the medical professionals present felt the situation "resolved" because I came to and appeared to then be breathing correctly. Afterward for many days I suffered from difficulty swallowing and felt pressure/pain to my chest area, with dyspnea. I was given adult Td and was declined being given TDaP because my immunization records at the time indicated that I had lifetime equivalent of the TDaP according to medical professionals at clinic.
Patient said the next day he had a low grade fever, body aches, and felt tired. Within 24 hours, symptoms resolved.
SWEATS, FELT LIKE THERE WAS A LUMP IN THROAT AND HAD DIFFICULTY SWALLOWING.  NO AIRWAY OBSTRUCTION.
My private felts like they were just sore/soreness in my testicle/my privates felt like they were tender; My privates felt like they were swollen/testicle; Heat flame over my whole body; Lost almost 3 pounds over night; Really bad back pain; Soreness in my right arm; Excruciating headache; This spontaneous case was reported by a consumer and describes the occurrence of TESTICULAR PAIN (My privates felt like they were just sore/soreness in my testicle/my privates felt like they were tender), TESTICULAR SWELLING (My privates felt like they were swollen/testicle), FEELING HOT (Heat flame over my whole body), WEIGHT DECREASED (Lost almost 3 pounds over night) and BACK PAIN (Really bad back pain) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Sep-2021, the patient experienced TESTICULAR PAIN (My private felts like they were just sore/soreness in my testicle/my privates felt like they were tender), TESTICULAR SWELLING (My privates felt like they were swollen/testicle), FEELING HOT (Heat flame over my whole body), WEIGHT DECREASED (Lost almost 3 pounds over night), BACK PAIN (Really bad back pain), VACCINATION SITE PAIN (Soreness in my right arm) and HEADACHE (Excruciating headache). The patient was treated with IBUPROFEN for Adverse event, at a dose of 1 dosage form. At the time of the report, TESTICULAR PAIN (My private felts like they were just sore/soreness in my testicle/my privates felt like they were tender) had not resolved, TESTICULAR SWELLING (My privates felt like they were swollen/testicle), FEELING HOT (Heat flame over my whole body) and WEIGHT DECREASED (Lost almost 3 pounds over night) outcome was unknown and BACK PAIN (Really bad back pain), VACCINATION SITE PAIN (Soreness in my right arm) and HEADACHE (Excruciating headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. The patient took one ibuprofen at night. Second shot was scheduled  on 13-Oct-2021.
This case was reported by a consumer via call center representative and described the occurrence of sickness in a patient who received SHINGRIX for prophylaxis. Previously administered products included shingles vaccine. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown. It was unknown if the reporter considered the sickness to be related to SHINGRIX. Additional details were received as follows: The age at vaccination was not reported. After receiving a dose of SHINGRIX, the patient was very sick. The physician thought that it might be reaction to shot because at the time of reporting, the patient had antibodies from the original live vaccine from several years before the reporting date. The physician recommended not to take 2nd dose of SHINGRIX. The patient was asking, what would happen if the patient would not receive the shot. Lab Comments: On an unknown date, the patient did lab test.